Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Enlaza Therapeutics, Inc.

Enlaza Therapeutics, Inc.

Stage unknownLa Jolla, CAPharmaceuticals
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
2 rounds
  1. Aug 29, 2025
    Form D equity offering · $15.0M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Enlaza Therapeutics, Inc. filed Form D: $15,000,000 sold of $15,000,000, Pharmaceuticals”
  2. Apr 5, 2024
    Form D equity offering · $84.0M (form d sold) · 16 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Enlaza Therapeutics, Inc. filed Form D: $84,000,000 sold of $110,000,000, Pharmaceuticals”
Investors on record
2 edges
People
3 officers, 5 directors
Timeline
2
  1. Sep 11, 2025
    Enlaza Therapeutics, Inc. filed Form D: $15,000,000 sold of $15,000,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Aug 9, 2024
    Enlaza Therapeutics, Inc. filed Form D: $84,000,000 sold of $110,000,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
32 observations
Every observation on this company